Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like Peter Marks Envisions New Development Model for Gene Therapies April 6, 2022 I3 Pharmaceuticals Draws Form 483 Over Quality Control Lapses July 1, 2022 Senate Dems: Novartis Misleadingly Downplayed Relationship With Trump Lawyer July 13, 2018